Nobivac® Lepto

Nobivac® Lepto

Inactivated vaccine for immunization in dogs against canine Leptospira

Description

Nobivac® Lepto

Inactivated vaccine for immunization in dogs against
canine leptospira caused by L. interrogans serogroup canicola &
icterohaemorrhagiae.

Description:
A bivalent, inactivated vaccine for the immunization of dogs against
leptospirosis caused by Leptospira canicola and Leptospira
icterohaemorrhagiae
.

Composition:
Each dose of inactivated vaccine contains:
Leptospira interrogans serotype Canicola strain Ca-12-000 at least
957 units/ml
Icterohaemorrhagiae strain 820k at least 625 units/m

Indications:
Active immunization against Leptospirosis caused by Leptospira icterohaemorrhagiae and Leptospira canicola of Leptospira
interrogans
. Animals are protected against clinical disease, and against
becoming renal carriers after challenge.

Dosage and Administration:
Inject 1ml of Nobivac Lepto subcutaneously. Nobivac Lepto can also be used to
reconstitute Intervet’s freeze dried vaccines, Nobivac Puppy DP and Nobivac DHPPi.

Vaccination Programme:
Nobivac Lepto is indicated for a basic vaccination schedule with a first
vaccination at the age of 8 – 9 weeks of age, followed by a booster at 12 weeks
of age, and for annual revaccination.
Vaccination with Nobivac Lepto, however is part of a comprehensive vaccination
programme.

Storage:
Between 2 – 8°C.

Contra-indications:
Hypersensitivity reactions following administrations are rare but as with
all vaccine may occasionally be encountered. In this event, administration of
adrenalin injection by the subcutaneous route may be indicated.

Presentation:
One box contains 10 vials of 1 dose.

MSD Product